Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-09-27
2005-09-27
Zucker, Paul A. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S544000, C514S683000, C560S020000, C560S073000, C560S106000, C568S329000
Reexamination Certificate
active
06949585
ABSTRACT:
The present invention provides a compound which has cytokine production inhibitory activity and is useful for the treatment of diseases which is associated with cytokine. The compound is represented by the following general formula (I) [wherein A represents a cyclic group which may be substituted; the partial structure -DE- represents a group represented by —CH2CH2— or —CH═CH—; W represents a group represented by —CH2—, —CH2CH2—, —CH═CH— or —CH═; the partial structure >XY— represents a group represented by >CH—(CH2)n—, >C═CH—, >CH—CH2—CH(OH)—, >CH—CH2—C(═O)—, >CH—O— or >CH—O—CO—, provided that when W is —CH═, then XY— represents C—(CH2)p—; Z represents a divalent aliphatic hydrocarbon group; R1and R2, which may be the same or different, each represents a hydrogen atom, or a hydroxyl, alkoxy or alkoxyalkoxy group; m is an integer of 0 or 1].
REFERENCES:
patent: 6140338 (2000-10-01), Naya et al.
patent: 0 934 940 (1999-08-01), None
patent: 1 008 346 (2000-06-01), None
patent: 1 018 514 (2000-07-01), None
patent: 62-81343 (1987-04-01), None
patent: WO 00/55139 (2000-09-01), None
Cope et al, Journal of Organic Chemistry, Cis- and Trans-1,5-Diphenylcyclooctane, 1964, pp. 3467-3469.
Peter Jones et al.,Zeitschrift fur Kristallographie,1983, 163:75-84.
Bruce Beutler et al.,Nature,1986, 320(17):584-588.
Tadamitsu Kishimoto,J. of Amer. Soc. of Hermatology,1989, 74(1):1-10.
Chiba Ken-ichi
Eguchi Yoshihito
Goto Masaki
Kuboi Yoshikazu
Obaishi Hiroshi
Eisai Co. Ltd.
Morgan & Finnegan LLP.
Zucker Paul A.
LandOfFree
Cyclooctanone derivatives and cyclodecanone derivative, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclooctanone derivatives and cyclodecanone derivative, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclooctanone derivatives and cyclodecanone derivative, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389138